Skin Laxity

0
Pipeline Programs
3
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
1100%
+ 5 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Apyx Medical
Apyx MedicalCLEARWATER, FL
3 programs
Renuvion APR HandpieceN/A1 trial
Renuvion APR SystemN/A1 trial
Renuvion APR SystemN/A1 trial
Active Trials
NCT05968495CompletedEst. Sep 2024
NCT05605691CompletedEst. Mar 2024
NCT06243744CompletedEst. Jul 2025
Lumenis
LumenisAustralia - Chatswood
2 programs
DMA treatmentN/A1 trial
triLift systemN/A1 trial
Active Trials
NCT04296201Completed15Est. Feb 2021
NCT05773924Unknown25Est. Aug 2023
Precision BioSciences
1 program
WonderLab Collagen Tripeptide DrinkN/APeptide1 trial
Active Trials
NCT05682092Completed70Est. Mar 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Apyx MedicalRenuvion APR System
Apyx MedicalRenuvion APR Handpiece
LumenistriLift system
Precision BioSciencesWonderLab Collagen Tripeptide Drink
Apyx MedicalRenuvion APR System
LumenisDMA treatment

Clinical Trials (6)

Total enrollment: 110 patients across 6 trials

NCT06243744Apyx MedicalRenuvion APR System

Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery

Start: Nov 2023Est. completion: Jul 2025
N/ACompleted
NCT05968495Apyx MedicalRenuvion APR Handpiece

Measuring Renuvion Soft Tissue Contraction Using Ultrasound

Start: Jun 2023Est. completion: Sep 2024
N/ACompleted
NCT05773924LumenistriLift system

Evaluation of Efficacy and Safety of the triLift™ System

Start: Feb 2023Est. completion: Aug 202325 patients
N/AUnknown
NCT05682092Precision BioSciencesWonderLab Collagen Tripeptide Drink

Study of Collagen Efficacy on Skin Anti-aging in 30 to 50-Year-Old Women

Start: Jan 2023Est. completion: Mar 202370 patients
N/ACompleted
NCT05605691Apyx MedicalRenuvion APR System

Post-Market Lower Eyelid Treatment With Renuvion in Greece

Start: Oct 2022Est. completion: Mar 2024
N/ACompleted
NCT04296201LumenisDMA treatment

Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology

Start: Sep 2020Est. completion: Feb 202115 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space